According to @business, Sergey Brin’s nonprofit stands to gain about $242 million from MapLight Therapeutics’ upcoming IPO, even though Brin’s name does not appear in the company’s IPO filings (source: Bloomberg/@business, Oct 27, 2025). The report indicates the listing is imminent and adds to the 2025 biotech IPO calendar, making MapLight a name to watch for price discovery and first-day liquidity (source: Bloomberg/@business, Oct 27, 2025). The report does not cite any direct cryptocurrency market impact for BTC or ETH from this IPO (source: Bloomberg/@business, Oct 27, 2025).

According to @business, MapLight Therapeutics has filed for an IPO, making it one of the few biotechnology listings moving forward in a tough year for the sector (source: Bloomberg post dated Sep 19, 2025). The source highlights a weak 2025 biotech IPO pipeline and does not indicate any direct cryptocurrency market impact (source: @business).